Abstract:Objective:To summarize and evaluate the therapeutic effect of total anomalous pulmonary venous drainage with obstruction.Methods:The clinical data of 189 children treated with TAPVC surgery in Children's Hospital Affiliated to Zhejiang University School of Medicine from January 2010 to December 2019 were retrospectively analyzed, including 36 cases in the obstruction group and 153 cases in the non-obstruction group.The obstruction group contained 20 males and 16 females with age 1~140 (29.1±28.7) d and body weight at the time of operation 2.4~6.5 (3.6±0.9) kg.According to the postoperative death, the patients were further divided into the obstruction death group (5 cases) and the obstruction survival group (31 cases). Compare two groups of preoperative lactic acid levels, preoperative left ventricular end-diastolic volume index, extracorporeal circulation time, postoperative mechanical ventilation time, postoperative Extracorporeal Membrane Oxygenation (ECMO) support cases, delayed chest closure cases, multifunctional organ failure cases, peritoneal dialysis cases, arrhythmia cases, postoperative pulmonary hypertension crisis cases and pulmonary venous obstruction cases.35 cases were done with the vertical veins ligation and establishment of the connection between pulmonary vein and left atrium, without sutureless technique of pericardium in situ.Results:Comparing the obstruction group and the non-obstruction group, ages were (29.1±28.7) vs.(98.3±121.6) days, body weight (3.6±0.9) vs.(5.1±3.4) kg, neonatal cases 21 (58.3%) vs.32 (20.9%), pulmonary venous velocity (1.4±0.5) vs.(1.1±0.4) m/s, delayed chest closure cases 15(41.6%) vs.10(6.5%), death cases 5(13.9%) vs. 10(6.5%). There were statistically significant differences in age, body weight, neonatal proportion, pulmonary venous velocity, delayed chest closure and death between the two groups ( P<0.05). Comparing the obstruction death group and the obstruction survival group, lactic acid levels were (6.7±3.8) vs.(2.5±1.2) mmol/L, left ventricular end-diastolic volume indices (27.1±19.5) vs.(29.2±16.8) mL/m 2, extracorporeal circulation time (216.3±64.3) vs.(159.3±73.4) mins, postoperative mechanical ventilation time (17.5±13.5) vs.(4.8±5.2) d, ECMO support cases 3 (60%) vs.1 (3.2%), delayed chest closure cases 4(80%) vs.11(35.5%), multifunctional organ failure cases 3 (60%) vs.0, peritoneal dialysis cases 4(80%) vs.16(51.6%), arrhythmia 2(40%) vs.3(9.7%), pulmonary hypertension crisis cases 3(60%) vs.1(3.2%), pulmonary venous obstruction cases 2(40%) vs.4(12.9%) respectively.There were statistically significant differences in preoperative lactic acid, extracorporeal circulation time, postoperative mechanical ventilation time, ECMO support cases, multifunctional organ failure cases and postoperative pulmonary hypertension crisis cases between the two groups ( P<0.05). No pulmonary vein obstruction was found in the surviving children after 6 months of follow-up. Conclusion:The operative mortality of children with complete pulmonary vein obstruction was high.Various techniques were used to expand the anastomosis during the operation.The early death was related to multiple organ failure and the perioperative application of ECMO, delayed chest closure and peritoneal dialysis can reduce the mortality.Pulmonary vein obstruction induced to the medium and long-term death.

Efficacy of interventional therapy in pediatric patients with complex congenital heart disease of diminished pulmonary blood flow after palliative surgery

[Interventional Treatment and Early-Stage Follow-Up of Pulmonary Atresia with Intact Ventricular Septum].

[Transcatheter therapy of combined congenital heart diseases in children].

Surgical treatment of congenital pulmonary vein stenosis plus congenital heart disease

Long-term postoperative outcome of congenital heart defects with severe pulmonary hypertension in children

Surgical Treatment on Congenital Heart Disease with Severe Pulmonary Hypertension

[Percutaneous Balloon Aortic Valvuloplasty for Congenital Valvular Aortic Stenosis in Children].

Surgical treatment of 275 cases with complete transposition of the great arteries

The Clinical Effect of Lung Transplantation for Pediatric Pulmonary Artery Hypertension

Treatment of complete anomalous pulmonary venous drainage with obstruction

Broadband ISDN and asynchronous transfer mode (ATM)

Clinical significance of pulse indicator continuous cardiac output in pediatric patients undergoing open-heart surgery

Extracorporeal membrane oxygenation for the treatment of children with severe hemodynamic alteration in perioperative cardiovascular surgery

Early Rehabilitation Training Promotes Recovery of Lung Function in Patients with Congenital Heart Disease After Cardiopulmonary Bypass

Efficacy of venoarterial extracorporeal membrane oxygenation in pediatric patients undergoing repair of congenital heart disease

Surgical Treatment of Double Outlet Right Ventricle Complicated by Pulmonary Hypertension

Effects of treprostinil on pulmonary arterial hypertension during surgery for congenital heart disease complicated with severe pulmonary arterial hypertension

Comparative Analysis of Treatment Strategies for Postoperative Pulmonary Hypertensive Crisis in Congenital Heart Disease

Predictors of operability in children with severe pulmonary hypertension associated with congenital heart disease

Preclinical tolerance and pharmacokinetic assessment of MU-Gold, a novel chemotherapeutic agent, in laboratory dogs.

Perioperative Clinical Effect of Extracorporeal Membrane Oxygenation for Lung Transplantation in Idiopathic Pulmonary Hypertension Patients